| Table 2 - Cycles with and without LH supplementation: Amount of r-FSH administered | ||||||
| Trail | r-FSH +r-LH | r-FSH | WMD | 95%CI fixed | ||
|---|---|---|---|---|---|---|
| n | mean±sd(UI) | n | mean±sd(UI) | |||
| Griesinger 2005 | 55 | 2082.8±695.7 | 54 | 1875.4±646.4 | 207.4 | -44.8,459.6 |
| Sauer 2004 | 21 | 2214.2±612 | 21 | 2228.6±359.8 | -14.4 | -318.0,289.2 |
| Acevedo 2004 | 22 | 1738±407.2 | 20 | 1807.1±97.05 | -69.1 | -252.3,114.1 |
| Cédrin- Durnerin 2004 | 107 | 2235±729 | 94 | 2239±620 | -4 | -192.5,184.5 |
| Total. | 205 | 189 | ||||
| Pooled effect size Fixed effects (Mulrow-Oxman) |
8.51 | -98.2,115.2 | ||||
Z (test WMD + differs from 0)= 0.156 p=0.87
Non-combinability of studies
-Cohran Q = 3.183282 (df = 4) p=0.3642